Skip to main content
Signal8

Bioceres Crop Solutions Corp. (BIOX) Form 6-K — Nov 17, 2026

$BIOXForm 6-KFiled Nov 17, 2026, 3:41 PM ET0001104659-26-129015Original filing

Bioceres Crop Solutions (NASDAQ: BIOX) reported fiscal first quarter 2027 revenue of $53.8 million, down 22% year-over-year, driven by phasing in soybean-related products and a more competitive adjuvant and nutrition market in Argentina. Net loss from continuing operations widened 127% to $10.8 million from $4.7 million a year ago, while Adjusted EBITDA fell 62% to $5.3 million — though it marked a second consecutive quarter of sequential improvement.

Key figures

Revenue
53800000
Total Debt
221700000
Gross Profit
18800000
Cash Position
8700000
Sga
$17.4 million
Rd expense
$1.8 million (down 51%)
Gross margin
35.0% (down from 44.5%)
Total equity
$23.4 million (down from $34.1M at 6/30/2026)
Adjusted ebitda
$5.3 million (down 62% from $13.9M in 1Q26)
Net financial debt
$213.0 million
Crop nutrition revenue
$18.8 million (-20%)
Crop protection revenue
$29.1 million (-12%)
Seed integrated revenue
$5.9 million (-53%)
Secured notes short term
$112.0 million

AI analysis

Red flags6 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.